{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Sunnyvale",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "67521",
      "recalling_firm": "Lin-Zhi International Inc",
      "address_1": "670 Almanor Ave",
      "address_2": "N/A",
      "postal_code": "94085-3513",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "US Distribution including the states of SC, NC, LA, FL, TX,, AL and GA and Internationally to Germany.",
      "recall_number": "Z-1179-2014",
      "product_description": "Cannabinoids DAU Calibrator Control Level 1   (62.5 ng/mL)  This solution is prepared from non-sterile urine and should be handled as potentially infectious.  IVD;    The Cannabinoids (cTHC also known as THC version c) DAU negative and positive controls are human urine-based liquids and ready to use. The constituent is a processed drug-free human urine matrix, containing buffers, stabilizers, and less than 0.09 % of sodium azide. The controls are prepared by spiking known concentrations of 11-nor-\u00019-THC-9-COOH into the drug-free  matrix. cTHC is referenced as an abbreviation for 11-nor-\u00019-THC-9-COOH and it may be referred to simply as THC in the text of this report. The controls contain 37.5 ng/mL and 62.5 ng/mL of cTHC,¿¿ 10% by GC/MS or LC/MS analysis.    Lin Zhi International inc.  Sunnyvale, CA 94085    The Cannabinoid Drug of Abuse (DAU) negative and positive controls are used as assay quality control material to monitor the precision of the Lin-Zhi International, Inc. (LZI) Cannabinoid Enzyme Immunoassay (Ref # 0070c) on a number of automated clinical chemistry analyzers.",
      "product_quantity": "216 items",
      "reason_for_recall": "Product catalog #\u0019s 0007c Cannabinoid 37.5 ng/mL Control Level 1 and 0008c Cannabinoid  62.5 Control Level 2 of the lots mentioned may give decreased concentration readings towards  the end of their shelf life due to use of dated but unexpired secondary stock used to create the  products.",
      "recall_initiation_date": "20140206",
      "center_classification_date": "20140312",
      "termination_date": "20150310",
      "report_date": "20140319",
      "code_info": "Catalog number 0008c; lot number 1211160R; Expiration May 14, 2014."
    }
  ]
}